144 related articles for article (PubMed ID: 10534174)
1. Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas.
Cerilli LA; Swartzbaugh JR; Saadut R; Marshall CE; Rumpel CA; Moskaluk CA; Frierson HF
Hum Pathol; 1999 Oct; 30(10):1242-6. PubMed ID: 10534174
[TBL] [Abstract][Full Text] [Related]
2. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.
Gorgoulis VG; Koutroumbi EN; Kotsinas A; Zacharatos P; Markopoulos C; Giannikos L; Kyriakou V; Voulgaris Z; Gogas I; Kittas C
Mol Med; 1998 Dec; 4(12):807-22. PubMed ID: 9990866
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on chromosome 6q correlates with decreased thrombospondin-2 expression in human salivary gland carcinomas.
Kishi M; Nakamura M; Nishimine M; Ishida E; Shimada K; Kirita T; Konishi N
Cancer Sci; 2003 Jun; 94(6):530-5. PubMed ID: 12824879
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers.
Muzeau F; Fléjou JF; Thomas G; Hamelin R
Int J Cancer; 1997 Jul; 72(1):27-30. PubMed ID: 9212218
[TBL] [Abstract][Full Text] [Related]
7. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
[TBL] [Abstract][Full Text] [Related]
9. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.
Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS
Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal relationship between methylation status and loss of heterozygosity at the p14(ARF) locus in Australian and South African hepatocellular carcinomas.
Herath NI; Kew MC; Walsh MD; Young J; Powell LW; Leggett BA; MacDonald GA
J Gastroenterol Hepatol; 2002 Mar; 17(3):301-7. PubMed ID: 11982701
[TBL] [Abstract][Full Text] [Related]
11. Two distinct pathways of p16 gene inactivation in gallbladder cancer.
Tadokoro H; Shigihara T; Ikeda T; Takase M; Suyama M
World J Gastroenterol; 2007 Dec; 13(47):6396-403. PubMed ID: 18081229
[TBL] [Abstract][Full Text] [Related]
12. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis.
Nagao T; Sugano I; Ishida Y; Asoh A; Munakata S; Yamazaki K; Konno A; Iwaya K; Shimizu T; Serizawa H; Ebihara Y
Mod Pathol; 2002 Jul; 15(7):724-33. PubMed ID: 12118110
[TBL] [Abstract][Full Text] [Related]
13. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
14. p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx.
Jares P; Fernández PL; Nadal A; Cazorla M; Hernández L; Pinyol M; Hernández S; Traserra J; Cardesa A; Campo E
Oncogene; 1997 Sep; 15(12):1445-53. PubMed ID: 9333020
[TBL] [Abstract][Full Text] [Related]
15. p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding.
Prall F; Ostwald C; Weirich V; Nizze H
Hum Pathol; 2006 May; 37(5):578-85. PubMed ID: 16647956
[TBL] [Abstract][Full Text] [Related]
16. Analysis of p16 expression and allelic imbalance / loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cell Mol Med; 2006; 10(3):778-88. PubMed ID: 16989737
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma.
Rutherford S; Yu Y; Rumpel CA; Frierson HF; Moskaluk CA
Cancer Lett; 2006 May; 236(2):309-17. PubMed ID: 16054751
[TBL] [Abstract][Full Text] [Related]
18. Homozygous deletions of the CDKN2 gene and loss of heterozygosity of 9p in primary hepatocellular carcinoma.
Piao Z; Park C; Lee JS; Yang CH; Choi KY; Kim H
Cancer Lett; 1998 Jan; 122(1-2):201-7. PubMed ID: 9464511
[TBL] [Abstract][Full Text] [Related]
19. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.
Merbs SL; Sidransky D
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):779-83. PubMed ID: 10067984
[TBL] [Abstract][Full Text] [Related]
20. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
